BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18991289)

  • 1. Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC.
    Waibler Z; Anzaghe M; Konur A; Akira S; Müller W; Kalinke U
    Eur J Immunol; 2008 Nov; 38(11):3127-37. PubMed ID: 18991289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacytoid dendritic cells induce a distinct cytokine pattern in virus-specific CD4+ memory T cells that is modulated by CpG oligodeoxynucleotides.
    Farkas L; Kvale EO; Lund-Johansen F; Jahnsen FL
    Scand J Immunol; 2006 Oct; 64(4):404-11. PubMed ID: 16970682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine thymic plasmacytoid dendritic cells.
    Okada T; Lian ZX; Naiki M; Ansari AA; Ikehara S; Gershwin ME
    Eur J Immunol; 2003 Apr; 33(4):1012-9. PubMed ID: 12672067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC.
    Meyers JA; Mangini AJ; Nagai T; Roff CF; Sehy D; van Seventer GA; van Seventer JM
    Cytokine; 2006 Sep; 35(5-6):235-46. PubMed ID: 17052915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production.
    Basner-Tschakarjan E; Gaffal E; O'Keeffe M; Tormo D; Limmer A; Wagner H; Hochrein H; Tüting T
    J Gene Med; 2006 Nov; 8(11):1300-6. PubMed ID: 16952196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells.
    Marschner A; Rothenfusser S; Hornung V; Prell D; Krug A; Kerkmann M; Wellisch D; Poeck H; Greinacher A; Giese T; Endres S; Hartmann G
    Eur J Immunol; 2005 Aug; 35(8):2347-57. PubMed ID: 16025562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of secondary structure of toll-like receptor 9 agonists on interferon alpha induction.
    Yu D; Putta MR; Bhagat L; Dai M; Wang D; Trombino AF; Sullivan T; Kandimalla ER; Agrawal S
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4320-5. PubMed ID: 18852281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
    Guiducci C; Ott G; Chan JH; Damon E; Calacsan C; Matray T; Lee KD; Coffman RL; Barrat FJ
    J Exp Med; 2006 Aug; 203(8):1999-2008. PubMed ID: 16864658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.
    Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T
    Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
    Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
    J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL; Tang LF; Lew FC; Wong HS; Chua YL; MacAry PA; Kemeny DM
    J Immunol; 2009 Jul; 183(1):41-50. PubMed ID: 19535645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E; Berg M; Magnusson M
    Vet Immunol Immunopathol; 2005 Sep; 107(3-4):265-79. PubMed ID: 15955566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
    Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
    Gray RC; Kuchtey J; Harding CV
    J Leukoc Biol; 2007 Apr; 81(4):1075-85. PubMed ID: 17227820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
    Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
    Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical swine fever virus induces activation of plasmacytoid and conventional dendritic cells in tonsil, blood, and spleen of infected pigs.
    Jamin A; Gorin S; Cariolet R; Le Potier MF; Kuntz-Simon G
    Vet Res; 2008; 39(1):7. PubMed ID: 18073094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.
    Schroeder JT; Chichester KL; Bieneman AP
    J Allergy Clin Immunol; 2008 Feb; 121(2):486-91. PubMed ID: 18036648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells.
    Danis B; George TC; Goriely S; Dutta B; Renneson J; Gatto L; Fitzgerald-Bocarsly P; Marchant A; Goldman M; Willems F; De Wit D
    Eur J Immunol; 2008 Feb; 38(2):507-17. PubMed ID: 18200500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.